Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan

Core Insights - Oxford Nanopore Technologies and A.D.A.M. Innovations have announced an international collaboration aimed at advancing genomic medicine in Japan, focusing on the deployment of nanopore sequencing technology [1][2][3] Collaboration Details - The collaboration will leverage Oxford Nanopore's real-time sequencing technology to enhance A.D.A.M. Innovations' genetic testing capabilities, enabling rapid and precise genomic testing across various diseases [2] - The initiative aims to introduce new clinical workflows that comply with Japan-specific validation standards, facilitating scalable sequencing of DNA fragments of any length [2][3] Strategic Importance - This partnership is part of the UK-Japan Health Memorandum of Cooperation, highlighting the collaboration between UK and Japanese expertise to improve patient outcomes through advanced genomic capabilities [3][4] - The collaboration is expected to strengthen industrial cooperation and accelerate translational research, benefiting real-world patient care [4] Company Backgrounds - Oxford Nanopore Technologies specializes in nanopore-based sensing technology for DNA and RNA analysis, with applications in over 125 countries [4] - A.D.A.M. Innovations, founded in 2004, is a leader in genomics and precision health solutions in Japan, having conducted over 2.9 million genetic tests and maintaining the largest R&D genomic database of the Japanese population [6]